骨质疏松症个体化治疗的实践策略
尽管有多种高效药物,美国骨折率近年趋于平稳或上升。本文旨在为临床医生提供偏好敏感的策略,以回应绝经后骨质疏松女性对营养、运动及药物顾虑的常见问题,并通过两个案例展示如何整合药物与生活方式指导、开展共享决策以制定个体化目标一致的护理计划。
要点
- 临床指南基于骨折风险指导药物选择,但个体化整合患者价值观的指导有限。
- 提供基于证据的营养建议及安全有效的抗阻、冲击和平衡训练指导。
- 通过共享决策回应患者对起始药物治疗的顾虑,制定目标一致的方案。
核心结论
- 临床医生可借助偏好敏感策略,将药物治疗与循证生活方式指导相结合,通过共享决策制定个体化、目标一致的骨质疏松护理计划。
研究设计与样本
- 本文为方法学论述,通过两个 illustrative 案例展示个体化治疗策略,未报告系统检索范围或样本量。
主要发现
- 美国骨折率近年趋于平稳或上升,尽管有多种高效药物可用。
- 骨质疏松患者常寻求营养、运动等生活方式指导,但内分泌科医生在常规诊疗中时间和专业知识有限。
关键数值与推荐
- 当前临床实践指南基于骨折风险提供药物选择方向,但对整合患者价值观、信念和偏好的个体化治疗指导有限。
临床怎么用
- 临床医生应提供基于证据的营养建议及安全有效的抗阻、冲击和平衡训练指导,以改善骨健康和预防跌倒。
- 对不愿起始药物治疗的患者,应采用共享决策回应顾虑,制定个体化目标一致的护理计划。
局限性
- 本文未报告原始研究数据或系统评价,所述策略基于专家观点和案例,缺乏疗效验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite the availability of multiple highly effective pharmacologic therapies for osteoporosis, fracture rates in the United States have plateaued or increased in recent years. At the same time, individuals with osteoporosis are exposed to an abundance of digital health information and frequently seek guidance on nutrition, exercise, and other lifestyle strategies to improve bone health. Many endocrinologists, however, may have limited time or expertise to address these questions comprehensively during routine clinical encounters. Current clinical practice guidelines provide valuable direction on selecting pharmacotherapy based on fracture risk, yet they offer limited guidance on how to personalize treatment plans by integrating patient values, beliefs, and preferences. The aim of this manuscript is to equip clinicians with practical, preference-sensitive strategies to address common concerns raised by postmenopausal women with osteoporosis, including evidence-based guidance on nutrition and on safe, effective resistance, impact, and balance-focused exercises for bone health and fall prevention. We also outline suggested approaches for responding to common concerns among patients who are reluctant to initiate pharmacologic therapy. Through 2 illustrative cases, we highlight how clinicians can integrate pharmacologic options with evidence-based lifestyle guidance and engage patients in shared decision making to develop individualized, goal-concordant care plans. Our goal is to provide clinicians with tools that support more effective, patient-centered conversations and ultimately improve the quality of osteoporosis care.
引用
- Woods G, Wooldridge JS, Weaver CM, et al. Approach to personalizing the treatment of osteoporosis. J Clin Endocrinol Metab. 2026. PMID: 42363701. doi:10.1210/clinem/dgag257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。